IT201600093764A1 - UNSAPONIFYABLE OF NATURAL LIPIDS FOR USE IN THE TREATMENT OF RHEUMATIC DISEASES - Google Patents

UNSAPONIFYABLE OF NATURAL LIPIDS FOR USE IN THE TREATMENT OF RHEUMATIC DISEASES

Info

Publication number
IT201600093764A1
IT201600093764A1 IT102016000093764A IT201600093764A IT201600093764A1 IT 201600093764 A1 IT201600093764 A1 IT 201600093764A1 IT 102016000093764 A IT102016000093764 A IT 102016000093764A IT 201600093764 A IT201600093764 A IT 201600093764A IT 201600093764 A1 IT201600093764 A1 IT 201600093764A1
Authority
IT
Italy
Prior art keywords
unsaponifyable
treatment
rheumatic diseases
natural lipids
lipids
Prior art date
Application number
IT102016000093764A
Other languages
Italian (it)
Inventor
Gregorio Chiara De
Original Assignee
Codex V Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codex V Srl filed Critical Codex V Srl
Priority to IT102016000093764A priority Critical patent/IT201600093764A1/en
Priority to PCT/IB2017/055624 priority patent/WO2018051296A2/en
Publication of IT201600093764A1 publication Critical patent/IT201600093764A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
IT102016000093764A 2016-09-19 2016-09-19 UNSAPONIFYABLE OF NATURAL LIPIDS FOR USE IN THE TREATMENT OF RHEUMATIC DISEASES IT201600093764A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102016000093764A IT201600093764A1 (en) 2016-09-19 2016-09-19 UNSAPONIFYABLE OF NATURAL LIPIDS FOR USE IN THE TREATMENT OF RHEUMATIC DISEASES
PCT/IB2017/055624 WO2018051296A2 (en) 2016-09-19 2017-09-18 Non—saponifiable compounds of natural lipids for use in the treatment of rheumatic pathologies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000093764A IT201600093764A1 (en) 2016-09-19 2016-09-19 UNSAPONIFYABLE OF NATURAL LIPIDS FOR USE IN THE TREATMENT OF RHEUMATIC DISEASES

Publications (1)

Publication Number Publication Date
IT201600093764A1 true IT201600093764A1 (en) 2018-03-19

Family

ID=58455403

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102016000093764A IT201600093764A1 (en) 2016-09-19 2016-09-19 UNSAPONIFYABLE OF NATURAL LIPIDS FOR USE IN THE TREATMENT OF RHEUMATIC DISEASES

Country Status (2)

Country Link
IT (1) IT201600093764A1 (en)
WO (1) WO2018051296A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1807747A1 (en) * 1967-11-24 1969-06-12 Evert Dijk Compositions contg camphor for treatment of eczema etc
RU2163481C1 (en) * 2000-05-26 2001-02-27 Котикова Марина Анатольевна Fir cream-balsam and its versions
WO2002072035A2 (en) * 2001-03-14 2002-09-19 Lipogenics, Inc. Novel anti-inflammatory compositions and methods of use
WO2008114125A1 (en) * 2007-03-21 2008-09-25 Codex S.R.L. Compositions containing compounds having steroid structure and their use for inducing the proliferation and differentiation of stem cells of the organism

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299264B1 (en) * 1998-05-15 2000-02-29 Codex V S R L TOPICAL PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF SKIN DISEASES ON AN INFLAMMATORY, IMMUNE OR PROLIFERATIVE BASIS
CN1367699A (en) * 1999-07-09 2002-09-04 Bsp药物有限公司 Composition containing extracts of butyrospermum parkii and use as medicament or dietary supplement
ES2272689T3 (en) * 2001-01-12 2007-05-01 Bsp Pharma A/S DIHYDRO-TRITERPENS IN THE TREATMENT OF VIRAL INFECTIONS, CARDIOVASCULAR DISEASE, INFLAMMATION, HYPERSENSITIVITY OR PAIN.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1807747A1 (en) * 1967-11-24 1969-06-12 Evert Dijk Compositions contg camphor for treatment of eczema etc
RU2163481C1 (en) * 2000-05-26 2001-02-27 Котикова Марина Анатольевна Fir cream-balsam and its versions
WO2002072035A2 (en) * 2001-03-14 2002-09-19 Lipogenics, Inc. Novel anti-inflammatory compositions and methods of use
WO2008114125A1 (en) * 2007-03-21 2008-09-25 Codex S.R.L. Compositions containing compounds having steroid structure and their use for inducing the proliferation and differentiation of stem cells of the organism

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 199018, Derwent World Patents Index; AN 1990-137383, XP002771969 *
DATABASE WPI Week 200130, Derwent World Patents Index; AN 2001-289040, XP002771968 *

Also Published As

Publication number Publication date
WO2018051296A3 (en) 2018-04-26
WO2018051296A2 (en) 2018-03-22

Similar Documents

Publication Publication Date Title
CY1124729T1 (en) PHARMACEUTICAL FORMS OF ENZALUTHAMIDE
BR112015022854A2 (en) fumarate prodrugs and their use in the treatment of various diseases
BR112016026378A2 (en) formulations and methods for keratin treatment
BR112019005908A2 (en) use of anti-pd-1 antibody and vegfr inhibitor combination in cancer drug preparation
GB201517215D0 (en) Use of cannabinoids in the treatment of inflammatory skin diseases
BR112016027041A2 (en) PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER
DK3532067T3 (en) LIPOSOMAL FORMULATION FOR USE IN THE TREATMENT OF CANCER
DK3882250T3 (en) TETRAHYDROPYRANYL-AMINO-PYRROLOPYRIMIDINONE FOR USE IN THE TREATMENT OF BTK-MEDIATED DISORDERS
BR112016017112A2 (en) APILIMOD COMPOSITIONS AND METHODS OF USE THEREOF
DK3253208T3 (en) Combination therapies for use in the treatment of breast cancer
DK3149049T3 (en) IL-22 FOR USE IN THE TREATMENT OF METABOLISM DISEASES
DK3408265T3 (en) THERAPEUTIC RELATIONS
DK3463436T3 (en) VACCINE IN COMBINATION WITH AN IMMUNE CHECKPOINT INHIBITOR FOR USE IN THE TREATMENT OF CANCER
IT201600081379A1 (en) Pharmaceutical composition for use in the treatment of prostatic diseases.
DK3419673T3 (en) GENERATION THERAPY FOR THE TREATMENT OF DISEASE IN THE TAPAL CELLS OF THE RINTH
MA50358A (en) SEMAGLUTIDE IN MEDICAL THERAPY
BR112016012002A2 (en) VITANOLIDS USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
IT201700111939A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF INFLAMMATORY STATES
KR20180084983A (en) Uses of Pyrimido-Pyrimidazinone for the Treatment of Cancer
IT201600093758A1 (en) UNSAPONIFYABLE OF NATURAL LIPIDS FOR USE IN THE TREATMENT OF TUMOR PATHOLOGIES
ES1165083Y (en) DEVICE FOR THE POSITIONING OF PATIENTS IN RADIOTHERAPY TREATMENTS
IT201600093764A1 (en) UNSAPONIFYABLE OF NATURAL LIPIDS FOR USE IN THE TREATMENT OF RHEUMATIC DISEASES
IT201600093741A1 (en) UNSAPONIFYABLE OF NATURAL LIPIDS FOR USE IN THE TREATMENT OF CARDIAC DISEASES
IT201700066486A1 (en) Blood serum for use in the treatment of ophthalmological neurodegenerative diseases
KR20180085033A (en) PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF SKIN DISEASES